⌕
Bio-Rad Laboratories · BIO · NYSE
Tenet 47 · Mixed
Compare
$358.19−0.57%At closeTenet 47 · Mixed
$358.19−2.07 (−0.57%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Bio-Rad Laboratories (BIO) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Defense WorldNov 15, 2026 · 13:02 ET
Insider Selling: Bio-Rad Laboratories (NYSE:BIO) EVP Sells $539,882.00 in Stock

Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP James Barry sold 1,400 shares of the company's stock in a transaction on Monday, November 9th. The shares were sold at an average price of $385.63, for a total…

● Defense WorldNov 15, 2026 · 13:01 ET
Bio-Rad Laboratories (NYSE:BIO) Stock: Insider Courtney Enloe Sells 902 Shares

Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP Courtney Enloe sold 902 shares of the company's stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $386.17, for a t…

● Defense WorldNov 15, 2026 · 13:01 ET
Bio-Rad Laboratories (NYSE:BIO) Stock: Insider Jonathan Divincenzo Sells 919 Shares

Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) COO Jonathan Divincenzo sold 919 shares of the stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $390.47, f…

● Defense WorldNov 15, 2026 · 12:19 ET
Bio-Rad Laboratories (NYSE:BIO) Stock: Insider James Barry Sells 1,400 Shares

Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP James Barry sold 1,400 shares of the company's stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $385.63, for a tota…

● Defense WorldNov 15, 2026 · 12:19 ET
Bio-Rad Laboratories, Inc. $BIO Stock Sold by Fisher Asset Management LLC

Fisher Asset Management LLC lessened its position in shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) by 1.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The…

● GlobeNewsWireNov 13, 2026 · 07:59 ET
BIO-key Q3 Software License Fees Grew 39%, Its Third Consecutive Quarter of Double-Digit Growth, Driven Primarily by Momentum in the Middle East and Europe; Hosts Call Today at 10am ET

HOLMDEL, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced its third q…

● GlobeNewsWireNov 12, 2026 · 16:15 ET
BIO GREEN MED SOLUTION REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

KUALA LUMPUR, MALAYSIA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; "BGMS" or the "Company"), a diversified company engaged primarily in the provision of fire safety protection and distr…

● GlobeNewsWireNov 11, 2026 · 08:27 ET
BIO-key Enters Gaming / Hospitality Market with Contract from Major U.S. Casino Resort

BIO-key entered gaming & hospitality market with contract from major U.S. casino resort to deploy PortalGuard® IAM platform and Identity-Bound Biometrics.…

● Seeking AlphaNov 10, 2026 · 12:41 ET
Bio-Rad Laboratories, Inc. (BIO) Presents at 2026 UBS Global Healthcare Conference Transcript

Bio-Rad Laboratories, Inc. ( BIO ) 2026 UBS Global Healthcare Conference November 10, 2026 8:00 AM EST Company Participants Roop Lakkaraju - Executive VP & CFO Conference Call Participants Douglas Schenkel - UBS Investme…

● GlobeNewsWireNov 10, 2026 · 07:30 ET
Dyadic Applied BioSolutions, BRIG BIO and Strive Nutrition Announce a Strategic Collaboration to Accelerate the Commercialization of Precision-Fermented Alpha-Lactalbumin for Premium Nutrition Markets in the U.S.

Dyadic Applied BioSolutions, BRIG BIO and Strive Nutrition Announce a Strategic Collaboration to Accelerate the Commercialization of Precision-Fermented Al…

● Zacks Investment ResearchNov 9, 2026 · 10:16 ET
Why Bio-Rad (BIO) International Revenue Trends Deserve Your Attention

Examine the evolution of Bio-Rad's (BIO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.…

● GlobeNewsWireNov 5, 2026 · 07:30 ET
Medicus Pharma to Present at BIO-Europe 2026

Medicus Chief Medical Officer will Highlight Company's Focus on Precision Oncology, Anchored by CD228V targeted ADC and Partner Ready Therapeutic Programs Medicus Chief Medical Officer will Highlight Company's Focus on P…

● MarketBeatNov 5, 2026 · 04:17 ET
What Bio-Rad Laboratories (BIO) Said on Its Q3 Earnings Call

Bio-Rad Laboratories NYSE: BIO reported modest third-quarter revenue growth, its first currency-neutral increase of 2026, as gains in clinical diagnostics and digital PCR instruments helped offset weakness in parts of it…

● Seeking AlphaNov 5, 2026 · 01:44 ET
Bio-Rad Laboratories, Inc. (BIO) Q3 2026 Earnings Call Transcript

Bio-Rad Laboratories, Inc. (BIO) Q3 2026 Earnings Call Transcript…

● Zacks Investment ResearchNov 4, 2026 · 18:51 ET
Bio-Rad Laboratories (BIO) Q3 Earnings Top Estimates

Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.65 per share, beating the Zacks Consensus Estimate of $2.61 per share. This compares to earnings of $2.26 per share a year ago.…

● Business WireNov 4, 2026 · 16:15 ETCOMPANY'S OWN WORDS
Bio-Rad Reports Third-Quarter 2026 Financial Results

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter end…

● PRNewsWireNov 3, 2026 · 20:30 ET
BIO-TECHNE DECLARES DIVIDEND

MINNEAPOLIS, Nov. 3, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September 30, 2026. The quarter…

● GlobeNewsWireNov 3, 2026 · 04:00 ET
Cipher, a Prosegur Company, and BIO-key Announce Technology Integration to Expand Identity Security Offering, Starting in Portugal

Cipher, a Prosegur Company, and BIO-key (BKYI) Announce Technology Integration to Expand Identity Security Offering Internationally, Starting in Portugal.…

● Business WireOct 29, 2026 · 16:30 ETCOMPANY'S OWN WORDS
Bio-Rad to Participate in Fireside Chat During UBS Global Healthcare Conference

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Financial Officer, Roop K. L…

● GlobeNewsWireOct 28, 2026 · 04:00 ET
BIO-key Deploys Identity Security Solution to New Customer Within a Middle East Government's National Security Ecosystem

RIYADH, Saudi Arabia and HOLMDEL, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global provider of Identity and Access Management (IAM) and biometric authentication solutions, toda…

● Seeking AlphaOct 26, 2026 · 12:10 ET
Ariel Fund Q3 2026 Leaders And Laggards

ZBRA's revenue growth accelerated across end markets and geographies, while margins and earnings exceeded expectations. CRL's results reflected improving demand across biopharma and biotechnology customers. Bio-Rad's sha…

● GlobeNewsWireOct 22, 2026 · 03:59 ET
BIO-key Secures Another Middle East Government Contract for its Passwordless, Biometric, Identity and Access Management Solutions

BIO-key (BKYI) secured another Middle East government contract (new customer) for its passwordless, biometric, identity & access management (IAM) solutions…

● GuruFocusOct 16, 2026 · 18:43 ET
Bio-Rad Laboratories Inc (BIO) Stock Down 3.0% but Still Overvalued -- GF Score: 73/100

On October 16, 2026, Bio-Rad Laboratories Inc (BIO) shares fell by 3.0%, bringing the current price to $353.70. The stock has experienced a 52-week range of $23…

● Business WireOct 14, 2026 · 09:00 ET
Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the third quarter of …

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

NVDA36−0.4%
INTC4−0.5%
LAW4−8.6%
ABR3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just BIO · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.